Carregant...
12/15-LOX inhibition or knockout reduces warfarin-associated hemorrhagic transformation following experimental stroke
BACKGROUND AND PURPOSE: For stroke prevention, patients with atrial fibrillation typically receive oral anticoagulation. The commonly used anticoagulant warfarin increases the risk of hemorrhagic transformation (HT) when a stroke occurs, however, and tissue plasminogen activator (tPA) treatment is r...
Guardat en:
| Publicat a: | Stroke |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5263178/ https://ncbi.nlm.nih.gov/pubmed/28057806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.014790 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|